mal scarring (8) . Some of the clinical features of EDS are actually evident in the families with ICH studied by Gensure et al. (6) , and this makes sense. But the reason why some ICH patients also develop acute bone lesions at a specific age is not clear. The authors hypothesize that periosteum is only loosely attached to the underlying bone structure in infants and that periosteum detachment (perhaps facilitated by the collagen mutation) would be the primum movens leading to increased bone formation. Such a hypothesis is not entirely consistent with the histologic studies done sequentially in cases of ICH (3) , which clearly indicate that inflammation is the initial event, in agreement with the clinical and PGErelated observations. It is noteworthy that Gensure et al. found that 79% of the individuals studied who were heterozygous for the COL1A1 mutation had an episode of cortical hyperostosis, while 21% of the subjects carrying the R836C substitution do not develop disease, which confirms the clinically observed reduced penetrance at the molecular level. Many unresolved questions regarding the pathology of this disease may have to wait for the engineering of an appropriate mouse model.
In conclusion, by showing convincingly that Caffey disease is associated with a COL1A1 missense mutation, Gensure et al. (6) (8) . This expansion of the T cell population can lead to a circumstance in which 30% of the CD8 + T cells in the peripheral blood mononuclear cell population are Tax specific. Tax is generally thought to transactivate transcription of regions of the HTLV-I genome as well as numerous cellular genes and is a major viral protein recognized in infected individuals. The expansion of the CD8 + T cell population could be due in part to dysregulation of infected CD4 + CD25 + T cells (9) .
Various investigators have found a high provirus load in individuals with inflammatory diseases such as HAM/TSP and HTLV-I-associated uveitis (10) (11) (12) (13) . A significant number of HAM patients also suffer from other inflammatory organ diseases such as leukoencephalopathy, infiltrates in the lungs, Sjögren syndrome, and arthropathy (14) . One of the reasons for the increase in inflammation and lymphoproliferation could be the dysregulation of the CD4 + CD25 + Treg population due to Tax expression, which leads to the unregulated expansion of either CD4 + or CD8 + T cells.
Tregs and FOXP3
CD4 + CD25 + Tregs express various cellsurface markers including CD62 ligand, CD103, CD152, and glucocorticoid-induced TNF receptor family-related protein (GITR; reviewed in ref. 15) . In humans, these cells express the forkhead transcription factor gene FOXP3 (the mouse homolog is Foxp3). FOXP3 encodes a forkhead/winged-helix family transcriptional repressor known as Scurfin (reviewed in ref. 16 ). These Tregs have the ability to decrease proliferation of and IL-2 production by CD4 + CD25 − T cells as well as expansion of CD8 + T cells. Humans with mutations or defects within the FOXP3 gene or its regulatory elements develop lymphoproliferative disease, which leads to autoimmune diseases such as dermatitis, type 1 diabetes, thyroid disease, anemia, and thrombocytopenia (16) . Induction of FOXP3 in CD4 + CD25 -T cells can convert these cells into a suppressor or regulatory phenotype (17) . Therefore, expression of FOXP3 correlates with their regulatory activity.
Tax regulates the regulator
Yamano et al. found increased levels of expression of FOXP3 mRNA in CD4 + CD25 + T cells compared with the expression levels in the CD4 + CD25 − T cells of HAM/TSP patients, asymptomatic HTLV-I-infected individuals (ACs), and uninfected healthy donors (HDs), as expected (2) . However, they also found a significantly lower level of FOXP3 expression in HAM/TSP CD4 + CD25 + T cells compared with that in CD4 + CD25 + T cells from the HD group (Figure 1) . In addition to conducting mRNA expression studies, the authors examined FOXP3 protein expression levels by flow cytometry. FOXP3 protein levels were found to correlate with mRNA expression, in that CD4 + CD25 + Tregs from HAM/TSP patients contained less FOXP3 than did CD4 + CD25 + cells from the HD group. These data indicate that HTLV-I-infected CD4 + CD25 + Tregs have reduced FOXP3 mRNA and protein expression. They also suggest that HTLV-Iinfected CD4 + CD25 + Tregs cannot modulate the proliferation of CD4 + CD25 − T cells. In coculture studies, Yamano et al. showed that this was indeed the case ( Figure 1 ). Mixing irradiated HTLV-I-infected CD4 + CD25 + T cells (from HAM/TSP patients) with uninfected, stimulated (via anti-CD3), nonirradiated CD4 + CD25 − T cells (from HDs) resulted in decreased suppression of CD4 + CD25 -T cell proliferation compared with the suppression seen in irradiated control CD4 + CD25 + T cells mixed with stimulated CD4 + CD25 − T cells (both from HDs) They found that transfection of the HTLV-I tax gene into purified CD4 + CD25 + T cells from HDs caused a decrease in FOXP3 expression, whereas transfection with the HTLV-I env gene did not (Figure 1 ). Interestingly, the CD4 + CD25 + T cells from HDs transfected with the HTLV-I tax gene lost their ability to suppress anti-CD3-induced CD4 + CD25 -T cell proliferation, whereas untransfected CD4 + CD25 + T cells were able to mediate this suppression.
Conclusions
It has been suggested that the tax-mediated mechanism described by Yamano et al. could be one of the reasons why HTLV-I-specific CD8 + T cells are so numerous in HAM/ TSP patients (18) . In HAM/TSP patients in whom a high proportion of the CD4 + CD25 + Tregs are infected with HTLV-I, the cells' ability to suppress the proliferation of viralspecific CTLs would be limited. It is has been previously shown that CD4 + CD25 + Tregs can inhibit the proliferation of CD8 + T cells (9) . Another hypothesis is that the inflammatory diseases associated with HTLV-I infection are related to defects in the ability of infected CD4 + CD25 + Tregs to modulate or regulate autoreactive CD4 + CD25 − T cells. The lack of suppression of these autoreactive 
